Inj apotex/bendamustine 1 mg
This code is not in the latest file (4Q26). It was last listed in 3Q24.
Payment limit per 1 MG, by effective quarter, 4Q23 to 3Q24. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J9058
No NDCs mapped to this code in the 4Q26 crosswalk.
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 3Q24 | $18.819 | −$5.315 | 1 MG | Inj apotex/bendamustine 1 mg | v1, posted June 11, 2025 |
| 2Q24 | $24.134 | +$3.356 | 1 MG | Inj apotex/bendamustine 1 mg | v1, posted March 11, 2025 |
| 1Q24 | $20.778 | −$12.28 | 1 MG | Inj apotex/bendamustine 1 mg | v1, posted December 19, 2024 |
| 4Q23 | $33.058 | – | 1 MG | Inj apotex/bendamustine 1 mg | v1, posted October 10, 2024 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024